SCHEMBL4668913

SCHEMBL4668913

O=CCN(CC1CCCCC1)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 4/20 0.48
HDAC1 Q13547 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
LMNA P02545 1/20 0.37
EPHX1 P07099 1/20 0.36
HPGD P15428 1/20 0.36
KMT2A Q03164 1/20 0.36
ADH1B P00325 1/20 0.35
ADH1C P00326 1/20 0.35
ADH1A P07327 1/20 0.35
ADH4 P08319 1/20 0.35
ADH7 P40394 1/20 0.35
MME P08473 2/20 0.35
SLC1A3 P43003 2/20 0.34
SLC1A2 P43004 2/20 0.34
SLC1A1 P43005 2/20 0.34
EPHX2 P34913 1/20 0.34
CYP2D6 P10635 1/20 0.33
PKM P14618 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4669117 0.81 KDM5A (0.39) ALOX5LMNAEPHX1HPGDKMT2A
SCHEMBL27787282 0.79 ALOX5 (0.32) ALOX5
SCHEMBL7471043 0.78 ALOX5 (0.50) ALOX5HDAC1HDAC6LMNAEPHX1
SCHEMBL1843886 0.75 EPHX1 (0.38) ALOX5HDAC6LMNAEPHX1HPGD
SCHEMBL2468579 0.73 LMNA (0.32) LMNA
SCHEMBL8773484 0.72 HDAC1 (0.61) HDAC1HDAC6LMNAKMT2AEPHX2
SCHEMBL7760755 0.71 ALOX5 (0.67) ALOX5HDAC1HDAC6EPHX1HPGD
SCHEMBL2413777 0.71 ALOX5 (0.46) ALOX5HDAC1HDAC6EPHX1HPGD
SCHEMBL25487468 0.70 ALOX5 (0.40) ALOX5EPHX1ADH1BADH1CADH1A
SCHEMBL29952531 0.69 ADH1A (0.40) ALOX5HDAC1HDAC6EPHX1ADH1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2001876-A2 8-AZABICYCLOÝ3.2.1¨OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS Theravance, Inc. (US) 2008-12-17 EP disclosed
WO-2007103187-A2 8-AZABICYCLO[3.2.1]OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS THERAVANCE, INC. (US) 2007-09-13 WO disclosed